Praxis Investment Management Inc. lessened its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 10.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,930 shares of the industrial products company's stock after selling 1,800 shares during the quarter. Praxis Investment Management Inc.'s holdings in Xylem were worth $1,931,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its holdings in shares of Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after acquiring an additional 3,239,203 shares during the period. Nuveen LLC purchased a new position in shares of Xylem during the 1st quarter worth $99,726,000. OVERSEA CHINESE BANKING Corp Ltd raised its holdings in Xylem by 390.5% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock valued at $122,009,000 after buying an additional 813,100 shares during the period. Swedbank AB raised its holdings in Xylem by 13.9% in the 2nd quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company's stock valued at $564,906,000 after buying an additional 531,890 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in Xylem by 46.8% in the 1st quarter. JPMorgan Chase & Co. now owns 1,363,453 shares of the industrial products company's stock valued at $162,878,000 after buying an additional 434,614 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.
Insider Buying and Selling at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at approximately $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company's stock.
Xylem Stock Performance
Shares of XYL opened at $144.53 on Friday. The stock has a 50 day moving average price of $143.25 and a 200 day moving average price of $131.03. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $35.18 billion, a price-to-earnings ratio of 37.54, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $151.16.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.
Analyst Ratings Changes
A number of analysts have issued reports on the stock. TD Cowen boosted their price target on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research note on Tuesday, August 26th. UBS Group boosted their price objective on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Stifel Nicolaus boosted their price objective on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Mizuho boosted their price objective on Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research report on Friday, September 12th. Finally, Barclays initiated coverage on Xylem in a research report on Friday, September 19th. They set an "overweight" rating and a $165.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $154.67.
Check Out Our Latest Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report